News & Updates

Findings from the SPOTLIGHT trial have shown the efficacy of administering durvalumab after chemoradiotherapy (CRT) in patients with unresectable stage III non-small-cell lung cancer (NSCLC).

High resting energy expenditure (REE) contributes to an increase in the risk of invasive breast cancer among postmenopausal women, as reported in a study.

Men who carry the G allele of melatonin receptor 1B gene (MTNR1B) rs10830963 are at lower risk of prostate cancer when exposed to night shift work, according to a study.

Income and several clinical factors are associated with placement and retrieval of inferior vena cava filter for patients with cancer-related thrombosis, a study has found. In addition, filter retrieval rates remain low despite reinitiation of anticoagulation in many patients.

Adult men with prostate cancer who have increasing exposure to androgen deprivation therapy (ADT) are at greater risk of dementia, according to a US study.

A supervised high-intensity interval training (HIIT) program for 12 weeks leads to improvements in prostate cancer-specific anxiety, fear of cancer progression, hormone symptoms, stress, fatigue, and self-esteem in men on active surveillance, reports a study.

While survival among multiple myeloma patients has been improving over time, the development of secondary primary malignancies seems to offset this effect by increasing the risk of mortality, a recent study has found.